Drug
Dexmedetomidine Hydrochloride Nasal Spray
Dexmedetomidine Hydrochloride Nasal Spray: highest development phase Phase 3, developed by Jiangsu Hengrui Medicine. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Jiangsu Hengrui Medicine
Trials
| Drug | Phase | Indication |
|---|---|---|
| dexmedetomidine hydrochloride nasal spray NCT04383418 | Phase 3 | Preoperative Sedation |
Latest
No recent events.
Follow Dexmedetomidine Hydrochloride Nasal Spray on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.